Anti-il4-il 13 bispecific antibodies
MA40164AUndetermined Publication Date: 2017-05-03SANOFI SA(FR)
0 Cites 0 Cited by
Patent Information
- Application Number
- MA40164
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2015-01-12
- Filing Date
- 2015-06-26
- Publication Date
- 2017-05-03
Abstract
Disclosed herein are safe doses of dual-v-region antibody-like binding proteins or fragments thereof, as well as methods for assessing binding of dual-v- region antibody-like proteins or fragments thereof to their targets, and methods of treating idiopathic pulmonary fibrosis (ipf) by administering safe doses of dual-v- region antibody-like binding proteins or fragments thereof. In some embodiments, the dual-v-region antibody-like binding proteins or fragments thereof bind both il-4 and il-13.
Need to check novelty before this filing date? Find Prior Art